These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8395157)

  • 21. [Paraneoplastic neurologic syndromes. 2. Lambert-Eaton myasthenic syndrome. 1) The molecular structure of calcium channel and immunology].
    Komai K; Iwasa K; Takamori M
    Nihon Naika Gakkai Zasshi; 1998 Apr; 87(4):678-84. PubMed ID: 9627477
    [No Abstract]   [Full Text] [Related]  

  • 22. Differential effect of Lambert-Eaton myasthenic syndrome immunoglobulin on cloned neuronal voltage-gated calcium channels.
    Pinto A; Moss F; Lang B; Boot J; Brust P; Williams M; Stauderman K; Harpold M; Newsom-Davis J
    Ann N Y Acad Sci; 1998 May; 841():687-90. PubMed ID: 9668315
    [No Abstract]   [Full Text] [Related]  

  • 23. Calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome.
    Leys K; Lang B; Johnston I; Newsom-Davis J
    Ann Neurol; 1991 Mar; 29(3):307-14. PubMed ID: 1645944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heterogeneity of calcium channel autoantibodies detected using a small-cell lung cancer line derived from a Lambert-Eaton myasthenic syndrome patient.
    Johnston I; Lang B; Leys K; Newsom-Davis J
    Neurology; 1994 Feb; 44(2):334-8. PubMed ID: 8309586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Review of evidence for loss of motor nerve terminal calcium channels in Lambert-Eaton myasthenic syndrome.
    Engel AG
    Ann N Y Acad Sci; 1991; 635():246-58. PubMed ID: 1660237
    [No Abstract]   [Full Text] [Related]  

  • 26. [Molecular immunology of voltage-gated calcium channel and Lambert-Eaton myasthenic syndrome].
    Iwasa K; Komai K; Yasukawa Y; Maruta T; Takamori M
    Nihon Rinsho; 1997 Dec; 55(12):3322-30. PubMed ID: 9436458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuronal staining patterns in sera from patients with Lambert-Eaton myasthenic syndrome.
    Polizzi A; Lang B; Amyes E; Newsom-Davis J; Vincent A
    Ann N Y Acad Sci; 1998 May; 841():684-6. PubMed ID: 9668314
    [No Abstract]   [Full Text] [Related]  

  • 28. A case report of the efficient reduction of calcium channel antibodies by tryptophan ligand immunoadsorption in a patient with Lambert-Eaton syndrome.
    Sauter M; Bender A; Heller F; Sitter T
    Ther Apher Dial; 2010 Jun; 14(3):364-7. PubMed ID: 20609193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lambert-Eaton myasthenic syndrome immunoglobulins react with multiple types of calcium channels in small-cell lung carcinoma.
    Meriney SD; Hulsizer SC; Lennon VA; Grinnell AD
    Ann Neurol; 1996 Nov; 40(5):739-49. PubMed ID: 8957015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuronal calcium channels as target for Lambert-Eaton myasthenic syndrome autoantibodies.
    Sher E; Carbone E; Clementi F
    Ann N Y Acad Sci; 1993 Jun; 681():373-81. PubMed ID: 8395151
    [No Abstract]   [Full Text] [Related]  

  • 31. A Lambert-Eaton myasthenic syndrome antigen associated with presynaptic calcium channels.
    Seagar MJ; Martin-Moutot N; Leveque C; el Far O; David P; Marqueze B; Lang B; Newsom-Davis J; Hoshino T; Takahashi M
    Biochem Soc Trans; 1993 May; 21(2):423-8. PubMed ID: 8395427
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunoassays fail to detect antibodies against neuronal calcium channels in amyotrophic lateral sclerosis serum.
    Arsac C; Raymond C; Martin-Moutot N; Dargent B; Couraud F; Pouget J; Seagar M
    Ann Neurol; 1996 Nov; 40(5):695-700. PubMed ID: 8957009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antigenic sites of the voltage-gated calcium channel in Lambert-Eaton myasthenic syndrome.
    Takamori M; Iwasa K; Komai K
    Ann N Y Acad Sci; 1998 May; 841():625-35. PubMed ID: 9668306
    [No Abstract]   [Full Text] [Related]  

  • 34. [Autoimmune myasthenia and Lambert-Eaton myasthenic syndrome. Physiopathologic concepts].
    Eymard B
    Ann Med Interne (Paris); 1989; 140(6):462-6. PubMed ID: 2696402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibodies against the beta subunit of voltage-dependent calcium channels in Lambert-Eaton myasthenic syndrome.
    Raymond C; Walker D; Bichet D; Iborra C; Martin-Moutot N; Seagar M; De Waard M
    Neuroscience; 1999 Apr; 90(1):269-77. PubMed ID: 10188953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Lambert-Eaton myasthenic syndrome.
    Sanders DB
    Adv Neurol; 2002; 88():189-201. PubMed ID: 11908225
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunological evidence for the co-existence of the Lambert-Eaton myasthenic syndrome and myasthenia gravis in two patients.
    Newsom-Davis J; Leys K; Vincent A; Ferguson I; Modi G; Mills K
    J Neurol Neurosurg Psychiatry; 1991 May; 54(5):452-3. PubMed ID: 1650816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies.
    Titulaer MJ; Lang B; Verschuuren JJ
    Lancet Neurol; 2011 Dec; 10(12):1098-107. PubMed ID: 22094130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Relationship between neuromuscular diseases and cancers].
    Takamori M
    Nihon Naika Gakkai Zasshi; 1999 Sep; 88(9):1841-51. PubMed ID: 10581772
    [No Abstract]   [Full Text] [Related]  

  • 40. Favourable prognosis in Lambert-Eaton myasthenic syndrome and small-cell lung carcinoma.
    Maddison P; Newsom-Davis J; Mills KR; Souhami RL
    Lancet; 1999 Jan; 353(9147):117-8. PubMed ID: 10023900
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.